Long-term outcomes with nonmyeloablative HLA-identical related HCT using tacrolimus and MMF for GVHD prophylaxis

Nonmyeloablative allogeneic hematopoietic cell transplantation (HCT) from HLA-identical related donors using cyclosporine (CSP) and mycophenolate mofetil (MMF) for post-grafting immunosuppression is effective therapy for hematologic cancers. However, graft-vs-host-disease (GVHD) remains a major caus...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Transplant Cell Ther
Autores principales: Oshima, Masumi Ueda, Storer, Barry E., Qiu, Huiying, Chauncey, Thomas, Asch, Julie, Boyer, Michael W., Giaccone, Luisa, Flowers, Mary, Mielcarek, Marco, Storb, Rainer, Maloney, David G, Sandmaier, Brenda M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8035484/
https://ncbi.nlm.nih.gov/pubmed/33830025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtct.2020.10.016
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares